Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to 24.43%.

  • Healthequity's EBITDA Margin rose 225300.0% to 24.43% in Q4 2025 from the same period last year, while for Oct 2025 it was 19.26%, marking a year-over-year increase of 108500.0%. This contributed to the annual value of 8.06% for FY2025, which is 24900.0% up from last year.
  • Per Healthequity's latest filing, its EBITDA Margin stood at 24.43% for Q4 2025, which was up 225300.0% from 27.5% recorded in Q3 2025.
  • Healthequity's 5-year EBITDA Margin high stood at 27.5% for Q3 2025, and its period low was 16.14% during Q1 2022.
  • Its 5-year average for EBITDA Margin is 4.52%, with a median of 2.38% in 2024.
  • In the last 5 years, Healthequity's EBITDA Margin crashed by -190000bps in 2022 and then soared by 225300bps in 2025.
  • Quarter analysis of 5 years shows Healthequity's EBITDA Margin stood at 2.8% in 2021, then soared by 73bps to 0.76% in 2022, then skyrocketed by 875bps to 5.89% in 2023, then crashed by -68bps to 1.9% in 2024, then surged by 1187bps to 24.43% in 2025.
  • Its EBITDA Margin was 24.43% in Q4 2025, compared to 27.5% in Q3 2025 and 16.3% in Q2 2025.